Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pharmaplast s.a.e amria free zone 23512 alexandria egypt -

Európska únia - slovenčina - EMA (European Medicines Agency)

biogen netherlands b.v. - natalizumab - roztrúsená skleróza - selektívne imunosupresíva - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 a 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi ab, Švédsko - aminokyseliny - 76 - infundibilia

Európska únia - slovenčina - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomide - roztrúsená skleróza - selektívne imunosupresíva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Európska únia - slovenčina - EMA (European Medicines Agency)

biogen netherlands b.v. - dimetylfumarát - roztrúsená skleróza - imunosupresíva - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Európska únia - slovenčina - EMA (European Medicines Agency)

mylan ireland limited - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Európska únia - slovenčina - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Európska únia - slovenčina - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - leukémia, myelogénna, chronická, bcr-abl pozitívna - antineoplastické činidlá - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Európska únia - slovenčina - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Európska únia - slovenčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomide - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresívami, selektívne imunosupresívami - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).